Infect Chemother.  2014 Jun;46(2):77-83. 10.3947/ic.2014.46.2.77.

Disclosure and Experienced Social Support are not Related to Anxiety or Depression in a German HIV Patient Cohort

• Kittner JM
• Brokamp F
• Thomaidis
• Schmidt RE
• Wiltink J
• Galle PR
• Jager B

• KMID: 2284983
• DOI: http://doi.org/10.3947/ic.2014.46.2.77

Abstract

BACKGROUND
It is unclear to which extent the rate of disclosure of the diagnosis "HIV" to the social environment and the nature of experienced responses are correlated with the current mental health status of HIV-infected patients living in Germany.
MATERIALS AND METHODS
Eighty consecutive patients of two German HIV outpatient clinics were enrolled. Patients performed the Hospital Anxiety and Depression Scale (HADS) in its German version. Disclosure behaviour and the experienced responses after disclosing as perceived by the participants were assessed using a questionnaire. In addition, patients were asked to state whether they felt guilty for the infection on a 1-4 point Likert scale.
RESULTS
Pathological results on the anxiety scale were reached by 40% of male and 73% of female patients, and on the depression scale by 30% of male and 47% of female patients, thus significantly exceeding recently assessed values in the German general population, except for depression in males. None of the HADS scale results was interrelated either with the rate of disclosure or the experienced responses. 36% of patients reported to feel guilty for the infection, which was positively correlated with results from the HADS. Limitation: The time since the single disclosure events was not assessed, and the subgroup of women was comparably small.
CONCLUSIONS
Despite substantial improvement in treatment, HIV-infected patients in Germany still suffer from an elevated level of anxiety and, in part, depression. However, mental health status was neither related with disclosure behaviour nor with experienced responses. We hypothesize that internal beliefs may play a more important role.

Keyword

Anxiety; Depression; Disclosure; HIV; Social support

MeSH Terms

Ambulatory Care Facilities
Anxiety*
Cohort Studies*
Depression*
Diagnosis
Disclosure*
Female
Germany
HIV*
Humans
Male
Mental Health
Social Environment
Surveys and Questionnaires

Reference

1. Van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. ATHENA national observational cohort study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010; 24:1527–1535.

2. Chun TW, Fauci AS. HIV Reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS. 2012; 26:1261–1268.

3. Bouhnik AD, Preau M, Schiltz MA, Obadia Y, Spire B. VESPA study group. Sexual difficulties in people living with HIV in France--results from a large representative sample of outpatients attending French hospitals (ANRSEN12-VESPA). AIDS Behav. 2008; 12:670–676.

4. Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, Szekeres G, Coates TJ. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008; 22:Suppl 2. S67–S79.

5. Angelino AF, Treisman GJ. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis. 2001; 33:847–856.

6. Kemppainen JK, Mackain S, Reyes D. Anxiety symptoms in HIV-infected individuals. J Assoc Nurses AIDS Care. 2013; 24:1 Suppl. S29–S39.

7. Song JY, Lee JS, Seo YB, Kim IS, Noh JY, Baek JH, Cheong HJ, Kim WJ. Depression among HIV-infected patients in Korea: assessment of clinical significance and risk factors. Infect Chemother. 2013; 45:211–216.

8. Hinz A, Schwarz R. Anxiety and depression in the general population: normal values in the Hospital Anxiety and Depression Scale. Psychother Psychosom Med Psychol. 2001; 51:193–200.

9. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.

10. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52:69–77.

11. Cairns JA, Johnston KM. Assessing the severity of depressive illness. J Clin Psychol. 1992; 48:455–462.

12. Hinz A, Brähler E. Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res. 2011; 71:74–78.

13. Jia H, Uphold CR, Wu S, Reid K, Findley K, Duncan PW. Health-related quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS. 2004; 18:594–603.

14. Uysal A, Lin HL, Knee CR. The role of need satisfaction in self-concealment and well-being. Pers Soc Psychol Bull. 2010; 36:187–199.

15. Woodward EN, Pantalone DW. The role of social support and negative affect in medication adherence for HIV-infected men who have sex with men. J Assoc Nurses AIDS Care. 2012; 23:388–396.

16. Collins NL, Miller LC. Self-disclosure and liking: a meta-analytic review. Psychol Bull. 1994; 116:457–475.

17. Audet CM, McGowan CC, Wallston KA, Kipp AM. Relationship between HIV stigma and self-isolation among people living with HIV in Tennessee. PLoS One. 2013; 8:e69564.

18. Kittner JM, Brokamp F, Jäger B, Wulff W, Schwandt B, Jasinski J, Wedemeyer H, Schmidt RE, Schattenberg JM, Galle PR, Schuchmann M. Disclosure behaviour and experienced reactions in patients with HIV versus chronic viral hepatitis or diabetes mellitus in Germany. AIDS Care. 2013; 25:1259–1270.

19. Herrmann C, Buss U, Snaith RP. HADS-D, hospital anxiety and depression scale-deutsche version; Ein Fragebogen zur Erfassung von Angst und Depressivitt in der somatischen Medizin. Testdokumentation und Handanweisung. Bern, Gttingen, Toronto, Seattle: Verlag Hans Huber;1995.

20. Arnold LM, Leon T, Whalen E, Barrett J. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia. Psychosomatics. 2010; 51:489–497.

21. Cohen M, Hoffman RG, Cromwell C, Schmeidler J, Ebrahim F, Carrera G, Endorf F, Alfonso CA, Jacobson JM. The prevalence of distress in persons with human immunodeficiency virus infection. Psychosomatics. 2002; 43:10–15.

22. Hansson M, Chotai J, Nordstom A, Bodlund O. Comparison of two self-rating scales to detect depression. Br J Gen Pract. 2009; 59:e283–e288.

23. Hintze J. Power analysis & sample size (PASS) software 2008. Accessed 28 February 2013. Available at: http://www.ncss.com.

24. Nel A, Kagee A. Common mental health problems and antiretroviral therapy adherence. AIDS Care. 2011; 23:1360–1365.

25. Robert-Koch Institute. German Epidemiological Bulletin 11/2013 (No 45). Accessed 15 December 2013. Available at: http://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2013/Ausgaben/11_13.pdf;jsessionid=20538032501F6E683E6F2A45F0B234FE.2_cid372?__blob=publicationFile.

26. Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess. 1998; 71:349–367.

27. Bayon C, Robertson K, de Alvaro C, Burogs A, Cabrero E, Esther N, et al. The prevalence of a positive screen for anxiety and/or depressive symptoms in HIV-1 infected patients across western Europe and Canada - The CRANium Study. In : Presented at the 2nd International HIV & Women; Bethesda, USA. 2012.

28. Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS. 1993; 7:425–431.

29. Clark HJ, Lindner G, Armistead L, Austin BJ. Stigma, disclosure, and psychological functioning among HIV-infected and non-infected African-American women. Women Health. 2003; 38:57–71.

30. Kalichman SC, DiMarco M, Austin J, Luke W, DiFonzo K. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med. 2003; 26:315–332.

31. Petrak JA, Doyle AM, Smith A, Skinner C, Hedge B. Factors associated with self-disclosure of HIV serostatus to significant others. Br J Health Psychol. 2001; 6:69–79.

32. Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one's HIV-positive status, stigma and social support. AIDS Care. 2008; 20:1266–1275.

33. Nachega JB, Morroni C, Zuniga JM, Sherer R, Beyrer C, Solomon S, Schechter M, Rockstroh J. HIV-Related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic). 2012; 11:172–178.

34. Schmid-Ott G, Kuensebeck HW, Jaeger B, Werfel T, Frahm K, Ruitman J, Kapp A, Lamprecht F. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol. 1999; 79:443–447.

35. Mak WW, Cheung RY, Law RW, Woo J, Li PC, Chung RW. Examining attribution model of self-stigma on social support and psychological well-being among people with HIV+/AIDS. Soc Sci Med. 2007; 64:1549–1559.

36. Warriner EM, Rourke SB, Rourke BP, Rubenstein S, Millikin C, Buchanan L, Connelly P, Hyrcza M, Ostrowski M, Der S, Gough K. Immune activation and neuropsychiatric symptoms in HIV infection. J Neuropsychiatry Clin Neurosci. 2010; 22:321–328.